Target intelligence / Profile preview

Protein cysteine residues susceptible to S-glutathionylation (PSSG)

Target
PSSG
Molecular classification
Post-translational modification, Redox-sensitive thiol, Other
01

Overview

Protein cysteine residues susceptible to S-glutathionylation represent a specific class of reactive thiols that undergo the reversible formation of disulfide bonds with glutathione. This post-translational modification (PTM) serves as a critical mechanism for redox signaling and protects essential protein thiols from irreversible oxidative damage, such as sulfonic acid formation, during periods of oxidative stress (Gallogly & Mieyal, 2007). The susceptibility of a specific cysteine residue to S-glutathionylation is determined by its local environment, including its pKa value and accessibility within the protein structure (Ghezzi, 2005). In various disease states, including cancer and cardiovascular disorders, the balance of S-glutathionylation is often disrupted, leading to the persistent inactivation or activation of key regulatory proteins like NF-kappaB, p53, and various protein phosphatases (Dalle-Donne et al., 2009). While not a single therapeutic target, these residues are the focus of drug development strategies aimed at modulating redox homeostasis or utilizing covalent inhibitors that target specific reactive cysteines. Therapeutic interventions often involve the use of antioxidants like N-acetylcysteine or the modulation of enzymes like glutaredoxin to restore normal protein function (Mieyal et al., 2008).

Other names
Protein S-glutathionylationGlutathionylated cysteinesRedox-sensitive cysteine residuesS-glutathionylated proteins
02

Mechanism of action

Modulation of the cellular redox environment to alter the ratio of reduced to oxidized glutathione, or direct enzymatic deglutathionylation via glutaredoxin (Grx) to restore protein function.

03

Biological functions

Redox signalingProtection against irreversible protein oxidationRegulation of enzyme activityProtein folding and stabilitySignal transduction
04

Disease associations

CancerCardiovascular diseaseNeurodegenerative diseaseChronic obstructive pulmonary disease (COPD)Diabetes mellitusInflammation
05

Safety considerations

Lack of specificity for individual proteinsPotential for systemic redox imbalanceOff-target effects due to the ubiquity of reactive cysteine residuesInterference with essential physiological redox signaling
06

Interacting drugs

N-acetylcysteine

3 more in the full profile.

07

Biomarkers

Protein-S-glutathione (PSSG) levelsGSH/GSSG ratioGlutaredoxin-1 activity

Beyond the preview

Go deeper on Protein cysteine residues susceptible to S-glutathionylation (PSSG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Protein cysteine residues susceptible to S-glutathionylation (PSSG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call